Michael Gross

Managing Director


Joined: 2008

Office Phone:

(248) 489-9000

  Pro - Try 1 Week Free

    and access,

  •     41K PE/M&A Contacts
  •     +
  •     3.9K PE Firms
  •     3.1K M&A Advisors
  •     139K Transactions
  •     148K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities


Michael is responsible for investment sourcing, deal execution and portfolio management, with a focus on healthcare, technology enabled services, and sustainability. Michael serves as a board director for Beringea portfolio companies MI Bioresearch, D3O, Delphinus Medical Technologies, InTouch Health, Intervention Insights, Xanitos, Freeosk, Rethink and Fiber By-Products. Previous portfolio companies include Pioneer Surgical Technologies (acquired by RTI Biologics), Relume Technologies (acquired by Revolution Lighting), and EcoSynthetix (offered publicly at TSX: ECO). Prior to joining Beringea, Michael was a vice president of investment banking with P&M Corporate Finance (PMCF). While at PMCF, Michael led M&A transactions and capital raises for companies in the life sciences, health care and outsourced business services sectors. Before working at PMCF, Michael worked in the investment banking group at Stout Risius Ross, Inc. Michael is a CFA charterholder and earned a B.A. in Finance from Michigan State University.


Michigan State University , Michigan,
1 of 113

Board Member

InTouch Health, Inc.

Delphinus Medical Technologies LLC

Freeosk, Inc.

Xanitos, Inc.

Molecular Imaging, Inc.

Intervention Insights, Inc.